Program Head, Phase Clinical Trials

Description

Associate Professor or Professor, CS, Phase I/Developmental Therapeutics Clinical Trials Program Head

The Fred Hutchinson Cancer Center (Fred Hutch) and the University of Washington (UW) invite nominations and applications to lead the Phase I Developmental Therapeutics clinical trials program. The position will be dual appointed with a primary faculty appointment in the Clinical Research Division at Fred Hutch and a secondary appointment in the UW Department of Medicine, Division of Hematology and Oncology.

The position will report to the Senior Vice President (SVP) of the Clinical Research Division at Fred Hutch and the Division Head of Hematology and Oncology at the UW.

We seek a visionary leader to head our Phase I Developmental Therapeutics Program, focusing on innovative therapies to provide hope and healing to cancer patients. This Program Head will lead and oversee the development and execution of early-phase clinical trials for novel cancer therapies. This role is crucial in translating groundbreaking research into clinical practice, ensuring the safe and efficient evaluation of new treatments.

The successful candidate will partner with leaders of the Fred Hutch immunotherapy integrated research center and cell-based therapy team to develop and execute an institutional early phase trial strategy. The Program Head will foster strong collaborations with translational researchers and clinical investigators at UW and Fred Hutch and will forge partnerships with biotech and pharmaceutical industry partners to grow the phase I program assets and advance our mission of delivering transformative cancer therapies to our patients.

The Program Head s overall responsibility will be to maintain and expand our Phase 1 clinical trials program in collaboration with our immune therapy and cell-based therapy teams. Specific tasks will include:

• Providing leadership in designing, implementing, and managing early-phase clinical trials
• Working on a team to oversee appropriate selection and placement of phase I trials
• Coordinating the infrastructure needed for optimal implementation of phase I studies, including research nurses, data coordinators, regulatory affairs, tissue acquisition, and biostatistical support
• Working with medical oncology and other faculty to assure patient accrual to studies
• Direct care of a portion of the study patients in addition to the faculty member s standard of care patients
• Outreach to community oncology providers to enhance access to Phase 1 trials

The candidate may also specialize in the treatment of a cancer subtype, in which case they could maintain a subspecialty clinic that is separate from their role as the Phase I Program Head. The incumbent will serve as an academic, clinical and educational leader charged with organizing, directing and expanding the research efforts for an established team of clinical researchers involved in conducting phase I trials.

Responsibilities include assisting with faculty recruitment as well as oversight and mentorship of faculty leading Phase I trials.

Appointment at Fred Hutch would be at the rank of associate or full professor in the Clinical Research Division of the Fred Hutch. Appointment to the full-time faculty at the UW would be at the rank of associate or full professor. Academic appointments at the University of Washington will be commensurate with experience, qualifications, and academic rank. Associate and full professors hold indefinite appointments that both align with a 12-month service period (July 1-June 30).

Faculty with 12-month service periods are paid for 11 months of service over a 12-month period (July-June), meaning the equivalent of one month is available for paid time off.

Opportunities exist for joint and/or affiliate appointment in the Fred Hutch Divisions of Public Health Sciences, Translational Science and Therapeutics, Human Biology, Basic Sciences, or Vaccine and Infectious Disease, depending on mutual interests. Fred Hutch and University of Washington faculty engage in teaching, research, and service.

The successful candidate will be appointed in the Clinician Scholar track and will spend approximately 30% of time on clinical care based on the candidate s interests (and institutional need). The remainder of the incumbent s time will be protected for research, administrative oversight of the Fred Hutch Phase I clinical research programs, teaching and mentorship, for the first three years, after which, the incumbent would be expected to cover at least half of their salary each year through grants, contracts, or clinical work.

Strong candidates will demonstrate evidence of both leadership of Phase I research and clinical excellence.

Faculty are expected to perform their primary activities on-site at Fred Hutch.

Fred Hutchinson Cancer Center is an independent, nonprofit organization providing adult cancer treatment and groundbreaking research focused on cancer and infectious diseases, based in Seattle. Fred Hutch is the only…